Scout Investments, Inc. Alkermes Plc. Transaction History

Scout Investments, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 14, 2018	SELL	$47.69 - $55.39 $5.34 Million - $6.2 Million	-111,932 Closed	0 $0
Q3 2017 Nov 03, 2017	SELL	$49.16 - $54.45 $13,764 - $15,246	-280 Reduced 0.25%	111,932 $5.69 Million
Q2 2017 Aug 08, 2017	BUY	N/A	112,212	112,212 $6.51 Million

375

166M

231K

158K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.42B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Scout Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Scout Investments, Inc. with notifications on news.